The US Food and Drug Administration approved a novel tool Tuesday that uses genetic testing to help assess whether certain people are at risk of developing opioid use disorder. The AutoGenomics AvertD ...
The first-ever DNA test to help determine if someone has a greater risk of developing opioid use disorder was approved by the Food and Drug Administration (FDA) this week. The FDA approved the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback